Association of Type 2 Diabetes Risk with Some Anthropometric Measurements in Obese Adults

Association of Type 2 Diabetes Risk with Some Anthropometric Measurements in Obese Adults

Authors

  • Nazal Bardak Perçinci European University of Lefke, Nutrition and Dietetics 

Keywords:

Obesity, Type 2 Diabetes, FINRISK

Abstract

Type 2 diabetes can be defined as an insidious disease that can last for years without symptoms. Disease In type 2 diabetes, insulin resistance and insulin secretion deformation are predominant and account for about 90-95% of all diabetics (5). The major disadvantage of delayed diagnosis is the increased risk of complications. The management of risk factors and risk factors that can be considered as a finding can prevent the disease or keep it uncomplicated (6). A total of 95 obese women adults with a mean age of 33.65 ± 1.62 years were included in this study. All cases were women. The Finnish Type-2 DM Risk Scale (FINRISK) was used to determine the risk of type 2 diabetes. FINDRISK (diabetes risks) scoring results of the participants are given in Table 2. According to this distribution, 15.8% of the participants were low risk, 26.3% were mild risk, 28.4% were medium risk, 13.7% were high risk and 15.8% were carries a very high risk. When body weight and risk scoring were evaluated, body weight was found to be statistically significant between the low-risk group and the high-risk group and the low-risk group and the medium-risk groups (<0.001). The difference between BMI values ​​between low risk group and medium risk group, low risk group and mild risk group and between high risk and very high risk groups were found to be statistically significant (<0.001). No statistical significance was found between height and body fat percentage (%) values. The difference between waist circumference, hip circumference and waist / hip ratio values ​​between low risk group and medium risk group, between low risk group and high risk group, and between mild risk and high risk groups were statistically significant (<0.001).

References

World Health Organization, “Obesity: Preventing and Managing The Global Epidemic”, Report of a WHO Conculcation, WHO Technical Report Series 894, Geneva, 2000.

Turkey Endocrinology and Metabolism Association (SEMT) Diagnosis of Diabetes Mellitus and its Complications, Treatment and Monitoring Guide-2017. Downloaded from http://temd.org.tr/admin/uploads/tbl_kilavuz/DI-YABET2017_web.pdf on 2/12/2019.

Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013; 28 (2): 169–80.

Coşansu G. Diabetes: A Global Epidemic. Okmeydanı Journal of Medicine 2015; 31 (Supplementary issue): 1-6.

American Diabetes Association. Prevention or delay of type 2 diabetes. Sec.5. Diabetes Care 2015; 38: 31-2.

The DPP Study Group. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. Diabetes Care 2000; 23 (11): 1619-29.

Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemi K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study Group. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003 Mar; 26 (3): 725-31.

Makrilakis K, Liatis S, Grammatikou S, Perrea D, et al. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab 2011; 37 (2): 144-151.

Hellgren MI, Petzold M, Björkelund C, Wedel H, et al. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study. Diabetes Med 2012; 29 (12): 1501-5.

Costa B, Barrio F, Piol JL, Cabré JJ, et al. The HbA1c diagnosis reduces the ability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy. BMC Medicine 2013; 11: 45.

Tarı Selçuk K, Determination of Type 2 Diabetes Risk in 45-74 Age Individuals in Bigadiç, PhD thesis, İzmir: Dokuz Eylül University; 2013.

Memiş S, Gökçe S, Gündoğmuş EE, Coşkunırmak D. Evaluation of diabetes risks of Health School students with type-2 diabetes in their families. Nursing forum journal of diabetes, obesity and hypertension; July-December (2014); Volume: 6, Issue: 2.

Aksakoglu G. Correlation and regression computation methods In: Aksakoglu G, eds. Research and analysis in health. 2. Printing. İzmir: DEÜ Rectorate Printing House; 2006. p. 283-90.

International Diabetes Federation 2013. http://www.idf.org/signs-and-symptoms-diabetes. Accessed on 06.12.2019.

WHO, 10 facts about diabetes, November 2014. http://www.who.int/features/factfiles/diabetes/facts/en/ (Accessed 06.12.2019).

International Diabetes Federation 2013. http://www.idf.org/signs-and-symptoms-diabetes. Accessed on 19.11.2013.

Coşansu G, Çelik SG, Olgun N, Özcan Ş, Demir HG. Determination of risk factors for Type-2 Diabetes in adults: an example of a community-based study. 49. National diabetes congress 1721 April 2013; 303. www.diabetes congress2013org. Access Date: 05.12.2019.

Taşdemir-Koçak HST, Öncel S, Zincir H, Sevig Ü. Determination of type 2 diabetes risk ratio and healthy lifestyle behaviors among classroom teachers. Public Health Activities - HASUDER, 16th National Public Health Congress, 2013.

Makrilakis K, Liatis S, Grammatikou S, Perrea D, et al. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab 2011; 37 (2): 144-151.

Chiasson JL, Josse RG, Gomis R, et al. STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomizedtrial. Lancet. 2002; 359 (9323): 2072-7.

Tankova T, Chakarova N, Atanassova I et al. Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucosetolerance and undetected diabetes. Diabetes Res Clin Pract. 2011; 92 (1): 46-52.

Costa B, Barrio F, Piñol JL, et al. The HbA1c diagnosis reduces the ability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities. BMC Med. 2013; 11: 45.

Downloads

Published

27-09-2022

Issue

Section

Original articles

How to Cite

1.
Bardak Perçinci N. Association of Type 2 Diabetes Risk with Some Anthropometric Measurements in Obese Adults. Progr Nutr [Internet]. 2022 Sep. 27 [cited 2025 Mar. 4];24(3):e2022121. Available from: https://mattioli1885journals.com/index.php/progressinnutrition/article/view/12566